A Randomized Phase II Study of Enhanced AR Blockade With Enzalutamide in High-Risk Patients With Biochemical Relapse Undergoing Salvage Radiation: Final Results From RTOG 3506 (STEEL)
Document Type
Conference Proceeding
Publication Date
9-2026
Publication Title
International Journal of Radiation Oncology, Biology, Physics
Volume
126
Issue
1 Suppl
First Page
S115
Last Page
S116
Recommended Citation
Posadas E, Gay HA, Pugh SL, Morgan TM, Xiao Y, Yu JB, et al. [Howell KJ]. A randomized phase II study of enhanced AR blockade with enzalutamide in high-risk patients with biochemical relapse undergoing salvage radiation: final results from RTOG 3506 (STEEL). Int J Radiat Oncol Biol Phys. 2026 Sep;126(1 Suppl):S115-S116. doi: 10.1016/j.ijrobp.2026.06.161
DOI
10.1016/j.ijrobp.2026.06.161
COinS
Comments
American Society for Radiation Oncology (ASTRO) 68th Annual Meeting September 26-30, 2026, Boston, MA